Scholars Central

Research articlePublished 2010

Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs

Authors: Yellela S.R. Krishnaiah

Journal of Bioequivalence & Bioavailability

Volume 2 · Issue 2 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The oral bioavailability of BCS (biopharmaceutics clas- sification system) class II drugs with poor solubility and reasonable permeability is limited by the drug dissolution step from drug products. Though prodrug approach is an exciting way of improving the oral bioavailability, it re- quires extensive studies to establish the safety profile of prodrugs in humans. In view of the increasing market share of oral drug products, a variety of technologies are devel- oped to enhance the oral bioavailability of poorly soluble drugs using the excipients with approved or GRAS (gener- ally regarded as safe) status. The present review describes the main technologies such as micronization, nanosizing, crystal engineering, solid dispersions, cyclodextrins, solid lipid nanoparticles and other colloidal drug delivery sys- tems with a few relevant research reports.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Yellela S.R. Krishnaiah”